Details of Disease

Disease Name

Acute gouty arthritis

Disease Class

FA25: Gout

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DISY5UJH: Acute gouty arthritis

ICD-11

ICD-11: FA25.0

ICD-10

ICD-10: M10.0

ICD-9

ICD-9: 274

Expand ICD-11

'FA25.0

Expand ICD-10

'M10.0

Expand ICD-9

274

Disease Identifiers

MONDO ID

MONDO_0024419

UMLS CUI

C1282952

MedGen ID

451081

HPO ID

HP:0100686

SNOMED CT ID

359643005

General Information of Disease (ID: DISY5UJH)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Colchicine	DM2POTE	Approved	Small molecular drug	[1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

This Disease Is Related to 2 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
HLA-B	TTGS10J	Strong	Biomarker	[2]
IL23A	TTC1GLB	Strong	Biomarker	[3]
------------------------------------------------------------------------------------

This Disease Is Related to 5 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
ACAD8	OT3JI5GB	Strong	Biomarker	[4]
CNTN3	OTC1274J	Strong	Biomarker	[5]
DEF6	OTIRBYVK	Strong	Biomarker	[6]
SERPINB1	OT5RDUFO	Strong	Biomarker	[7]
TRAPPC9	OTF0CVMC	Strong	Biomarker	[6]
------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7526).
2	Association Between Enthesitis and Health-related Quality of Life in Psoriatic Arthritis in Biologic-naive Patients from 2 Phase III Ustekinumab Trials.J Rheumatol. 2019 Nov;46(11):1458-1461. doi: 10.3899/jrheum.180792. Epub 2019 Apr 1.
3	Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study.Semin Arthritis Rheum. 2019 Feb;48(4):632-637. doi: 10.1016/j.semarthrit.2018.05.011. Epub 2018 Jun 13.
4	Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease.Rheumatology (Oxford). 2019 Jun 1;58(6):963-968. doi: 10.1093/rheumatology/key267.
5	Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study.Rheumatol Int. 2020 Feb;40(2):283-294. doi: 10.1007/s00296-019-04480-9. Epub 2019 Nov 26.
6	Factors associated with the decision of the rheumatologist to order sacroiliac joints magnetic resonance imaging (SI-MRI) or HLA-B27 testing in the diagnostic work-up of patients with spondyloarthritis in clinical practice.Clin Exp Rheumatol. 2017 Jan-Feb;35(1):122-128. Epub 2016 Oct 26.
7	Correlation of enthesitis indices with disease activity and function in axial and peripheral spondyloarthritis: a cross-sectional study comparing MASES, SPARCC and LEI.Adv Rheumatol. 2019 Jun 17;59(1):23. doi: 10.1186/s42358-019-0066-8.